Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
128.7 USD | +0.23% | +0.96% | +16.76% |
01:00am | Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM | |
Jun. 03 | Merck: promising results in melanoma treatment | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.76% | 325B | |
+43.14% | 748B | |
+33.98% | 598B | |
-5.96% | 356B | |
+3.37% | 283B | |
+16.87% | 245B | |
+9.19% | 211B | |
-4.21% | 209B | |
+1.77% | 166B | |
+6.97% | 165B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck treatment for a type of uterus cancer fails trial